1. Home
  2. BOW vs PLSE Comparison

BOW vs PLSE Comparison

Compare BOW & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOW
  • PLSE
  • Stock Information
  • Founded
  • BOW 2020
  • PLSE 2014
  • Country
  • BOW United States
  • PLSE United States
  • Employees
  • BOW N/A
  • PLSE N/A
  • Industry
  • BOW Property-Casualty Insurers
  • PLSE Medical/Dental Instruments
  • Sector
  • BOW Finance
  • PLSE Health Care
  • Exchange
  • BOW Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • BOW 1.1B
  • PLSE 1.3B
  • IPO Year
  • BOW 2024
  • PLSE 2016
  • Fundamental
  • Price
  • BOW $39.10
  • PLSE $16.85
  • Analyst Decision
  • BOW Buy
  • PLSE
  • Analyst Count
  • BOW 6
  • PLSE 0
  • Target Price
  • BOW $37.17
  • PLSE N/A
  • AVG Volume (30 Days)
  • BOW 288.1K
  • PLSE 163.1K
  • Earning Date
  • BOW 05-06-2025
  • PLSE 05-08-2025
  • Dividend Yield
  • BOW N/A
  • PLSE N/A
  • EPS Growth
  • BOW 18.99
  • PLSE N/A
  • EPS
  • BOW 1.33
  • PLSE N/A
  • Revenue
  • BOW $457,704,000.00
  • PLSE N/A
  • Revenue This Year
  • BOW $25.34
  • PLSE N/A
  • Revenue Next Year
  • BOW $20.94
  • PLSE N/A
  • P/E Ratio
  • BOW $29.49
  • PLSE N/A
  • Revenue Growth
  • BOW 45.29
  • PLSE N/A
  • 52 Week Low
  • BOW $22.14
  • PLSE $6.66
  • 52 Week High
  • BOW $42.29
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • BOW N/A
  • PLSE 48.34
  • Support Level
  • BOW N/A
  • PLSE $15.92
  • Resistance Level
  • BOW N/A
  • PLSE $18.06
  • Average True Range (ATR)
  • BOW 0.00
  • PLSE 0.95
  • MACD
  • BOW 0.00
  • PLSE -0.10
  • Stochastic Oscillator
  • BOW 0.00
  • PLSE 26.35

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: